BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32163579)

  • 1. Tofacitinib in cardiovascular outcomes: friend or foe?
    Xie W; Zhang Z
    Rheumatology (Oxford); 2020 Aug; 59(8):1797-1798. PubMed ID: 32163579
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in Lipid Levels and Incidence of Cardiovascular Events Following Tofacitinib Treatment in Patients With Psoriatic Arthritis: A Pooled Analysis Across Phase III and Long-Term Extension Studies.
    Gladman DD; Charles-Schoeman C; McInnes IB; Veale DJ; Thiers B; Nurmohamed M; Graham D; Wang C; Jones T; Wolk R; DeMasi R
    Arthritis Care Res (Hoboken); 2019 Oct; 71(10):1387-1395. PubMed ID: 31112005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoimmunology in rheumatoid and psoriatic arthritis: potential effects of tofacitinib on bone involvement.
    Orsolini G; Bertoldi I; Rossini M
    Clin Rheumatol; 2020 Mar; 39(3):727-736. PubMed ID: 31970549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tofacitinib in ulcerative colitis.
    Archer TP; Moran GW; Ghosh S
    Immunotherapy; 2016 May; 8(5):495-502. PubMed ID: 27140405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tofacitinib for the treatment of psoriasis and psoriatic arthritis.
    Berekmeri A; Mahmood F; Wittmann M; Helliwell P
    Expert Rev Clin Immunol; 2018 Sep; 14(9):719-730. PubMed ID: 30118353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tofacitinib Therapy, the Lender of Last Resort.
    Rutka M; Pigniczki D; Molnár T
    J Crohns Colitis; 2021 Apr; 15(4):694. PubMed ID: 32978625
    [No Abstract]   [Full Text] [Related]  

  • 7. Tofacitinib in psoriatic arthritis.
    Wang TS; Tsai TF
    Immunotherapy; 2017 Nov; 9(14):1153-1163. PubMed ID: 28967798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tofacitinib and Subacute Pneumonitis: Don't Hold Your Breath.
    Verstockt B; Pouillon L; Bossuyt P
    J Crohns Colitis; 2021 Apr; 15(4):692-693. PubMed ID: 33104197
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple esophageal ulcers due to tofacitinib 10 mg twice daily for ulcerative colitis.
    Tominaga K; Kanazawa M; Takenaka K; Tanaka T; Sugaya T; Fukushi K; Takagi Y; Nagashima K; Abe K; Izawa N; Tsuchida K; Iijima M; Goda K; Yamagishi H; Irisawa A
    Clin J Gastroenterol; 2020 Jun; 13(3):340-343. PubMed ID: 31705375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the Janus kinases in rheumatoid arthritis: focus on tofacitinib.
    Yamaoka K; Tanaka Y
    Expert Opin Pharmacother; 2014 Jan; 15(1):103-13. PubMed ID: 24188100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case Series on Patients on Tofacitinib in Combination With a Biologic.
    Barroso NS; Miller EZ; Furst DE
    J Clin Rheumatol; 2018 Sep; 24(6):349-351. PubMed ID: 29280829
    [No Abstract]   [Full Text] [Related]  

  • 12. Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors.
    Gladman D; Rigby W; Azevedo VF; Behrens F; Blanco R; Kaszuba A; Kudlacz E; Wang C; Menon S; Hendrikx T; Kanik KS
    N Engl J Med; 2017 Oct; 377(16):1525-1536. PubMed ID: 29045207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of tofacitinib for the treatment of psoriatic arthritis.
    Abdulrahim H; Sharlala H; Adebajo AO
    Expert Opin Pharmacother; 2019 Nov; 20(16):1953-1960. PubMed ID: 31456440
    [No Abstract]   [Full Text] [Related]  

  • 14. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis.
    Sandborn WJ; Su C; Sands BE; D'Haens GR; Vermeire S; Schreiber S; Danese S; Feagan BG; Reinisch W; Niezychowski W; Friedman G; Lawendy N; Yu D; Woodworth D; Mukherjee A; Zhang H; Healey P; Panés J;
    N Engl J Med; 2017 May; 376(18):1723-1736. PubMed ID: 28467869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct and Indirect Effects of Tofacitinib on Treatment Satisfaction in Patients with Ulcerative Colitis.
    Panés J; Su C; Bushmakin AG; Cappelleri JC; Healey P
    J Crohns Colitis; 2016 Nov; 10(11):1310-1315. PubMed ID: 27194530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgA Vasculitis Developed as an Adverse Effect of Tofacitinib Taken for Rheumatoid Arthritis.
    Itoh I; Kasuno K; Yamamoto C; Takahashi N; Shimizu H; Ojima T; Hayashi S; Kimura H; Iwano M
    Intern Med; 2020 Mar; 59(6):817-821. PubMed ID: 31813912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Summaries for patients: tofacitinib for the treatment of rheumatoid arthritis.
    Ann Intern Med; 2013 Aug; 159(4):I-26. PubMed ID: 24026272
    [No Abstract]   [Full Text] [Related]  

  • 18. Varicella zoster virus myelitis in a patient with rheumatoid arthritis treated by tofacitinib.
    Itamiya T; Komai T; Tsuchida Y; Shoda H; Fujio K
    Scand J Rheumatol; 2021 Jul; 50(4):319-321. PubMed ID: 32940139
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tofacitinib].
    Döker S; Dewenter M; El-Armouche A
    Dtsch Med Wochenschr; 2014 May; 139(19):1003-8. PubMed ID: 24782154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to Tofacitinib Not Related to Recurrence of Anal Premalignant Lesion: A Case Report.
    Queiroz NSF; Graciolli CB; Sobrado CW
    Inflamm Bowel Dis; 2020 Nov; 26(12):e155-e156. PubMed ID: 32676668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.